Dr. Fuller is a 2017 Sabin Family Foundation Fellow, as well as an Assistant Professor and Associate Director of MRI within the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. After his completing medical school and PhD training in Radiological Sciences (Human Imaging) at the University of Texas Health Science Center at San Antonio, Dr. Fuller joined MD Anderson in 2011, becoming a board-certified radiation oncologist in the Head and Neck Section, with subsequent subspecialty certification in Clinical Informatics. His research focus is in the development of evidence-based "precision radiotherapy" techniques by incorporation of novel MRI methodologies for normal tissue and tumor, leveraging innovative imaging informatics approaches to improve patient care through technology development.
Jim completed his PhD at the University of Queensland, Australia (UQ) in 2007 and a post-doctoral fellowship (2010) also at UQ (CCRE-Spine). His multidisciplinary teams' contributions to the field range from the identification of novel magnetic resonance imaging markers to quantify alterations in spinal cord anatomy and skeletal muscle degeneration as potential markers of poor functional recovery following head/neck trauma to leading large multidisciplinary studies investigating the neurobiological mechanisms of persistent spinal pain (generally) and head/neck trauma (e.g. whiplash injury) following a motor vehicle collision (specifically). He is currently a Professor of Allied Health in the Faculty of Health Sciences at the University of Sydney and the Northern Sydney Local Health District. Prior to this, Jim was a tenure-track Associate Professor in the Feinberg School of Medicine at Northwestern University in Chicago, USA, where he remains an adjunct Professor and Principal Investigator of the Neuromuscular Imaging Research Laboratory. Jim is passionate about mentoring the next generation of health, medical, and engineering researchers. His dedication to supervising students and post-doctoral fellows earned him recognition as the 2015 recipient of the Faculty Award for Engagement and the 2017 Ver Steeg Faculty Award for Excellence in working with Graduate Students from the Graduate School of Northwestern University. His collaborative work with clinicians, other researchers, and students from around the world aims to pioneer new scientific knowledge, diagnostics, and objective measures to inform and test new therapies towards permitting millions of patients with acute and chronic spinal pain to live a healthy, active life.
Dr. Ellingson is an Associate Professor of Radiology, Biomedical Physics, Psychiatry and Bioengineering at UCLA in the Departments of Radiology, Psychiatry, and Biobehavioral Sciences. Dr. Ellingson is the Director of the UCLA Brain Tumor Imaging Laboratory (BTIL) and Co-Director of the Center for Computer Vision and Imaging Biomarkers (CVIB). Dr. Ellingson possess a broad background in biomedical engineering, mathematics, quantum physics, molecular imaging, bioelectronics, and medical instrumentation. Dr. Ellingson's research focuses on the development, testing, validation, and implementation of advanced MR and PET imaging biomarkers for brain pathology and therapeutic response evaluation in human clinical trials. Dr. Ellingson serves as the principal investigator or chair of the imaging core in many industry and government-funded clinical trials, serves on many steering committees and holds many advisory roles related to neuro-oncology neuroimaging and has co-authored more than 100 peer-reviewed original research articles relating to neuroimaging.
Earned medical degree in 1979. After completing residencies and fellowship, attended Graduate School of Medicine at Kyoto University and got Ph.D. degree in 1987. During this period, mostly involved in the very early studies of body MR imaging especially in gynaecologic field, and published several articles including the one entitled "Uterine cervical cancer: assessment with high-field MR imaging" published in Radiology 1986. From that time, working as one of pioneers of gynaecologic MRI research for over 30 years, and published several books and over 400 articles in peer-reviewed journals in English. Starting with radiological-pathological correlation for cancer imaging, recent areas of interest are functional body MRI including cine MR to evaluate uterine functions, diffusion-weighted images in oncology, diffusion tensor imaging of the uterus, etc. After appointed to a professor and chairperson, dedicated to encouraging junior faculties to get interested in academic activities. A string of awards in the annual meetings of Radiological Society of North America (RSNA), European Congress of Radiology (ECR), and International Society for Magnetic Resonance in Medicine (ISMRM), Society of Nuclear Medicine etc. are all the fruits of this devotion. Honours include Honorary Membership of the ECR in 2007, Fellow of ISMRM in 2012, and the Honorary Member of RSNA in 2014.
Professor Hammers has been Head of the King's College London & Guy's and St Thomas' PET Centre since 2013. He is Professor of Imaging and Neuroscience and Interim Head (with René Botnar) of the School of Biomedical Engineering and Imaging Sciences. He trained in medicine and then in Neurology in Germany, France, and the UK. He obtained an MD in MR imaging of the hippocampus, and a PhD in PET investigations in focal epilepsy, before leading his own group at the Medical Research Council's Clinical Sciences Centre at Hammersmith Hospital, creating the Hammers_mith brain atlases. As Chair of Excellence in Functional Neuroimaging at the Neurodis Foundation in Lyon, France, 2009-2014, he wrote several of the grants that established France's first simultaneous PET-MR, before joining King's.
He is affiliated with several professional organisations, has won several distinctions, is an acclaimed teacher, and reviews frequently for numerous journals and grant-giving bodies. He is an author on about 200 articles, proceedings, and chapters (h index Web of Science 42, Google Scholar 50).
His research areas are functional imaging with PET to understand mechanisms of neurological disease, and structural neuroimaging using MRI and anatomical segmentation using the large manually annotated Hammers_mith brain atlas database. Both the PET and MR research are applied to the epilepsies and neurodegenerative diseases. The ultimate goal is to benefit individual patients through the clinical application of neuroscience, e.g. through classification and decision support with machine-learning techniques. In addition, methodological work is underpinning all applications, particularly for simultaneous PET-MR.
Dr. Frangou, MD, PhD, FRCPsych serves as Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, New York (http://www.frangougroup.org). Previously, Dr. Frangou led the Section of the Neurobiology of Psychosis at the Institute of Psychiatry, King's College London (KCL), UK. She received her PhD at KCL and completed her psychiatry training at the Maudsley Hospital, UK. Her work has greatly advanced the understanding of the pathophysiology of schizophrenia and bipolar disorder, particularly in relation to genetic and familial risk. She has made groundbreaking contributions to the characterization of brain mechanisms of "resilience" in those at high familial risk for psychosis. She has authored more than 200 highly cited papers and has written or contributed to ten books on mental illness. In 2016, she published "Women in Academic Psychiatry: A Mind to Succeed" to promote women psychiatrists aiming for academic leadership positions.
Dr. Frangou is a fellow of the European Psychiatric Association (EPA), the Royal College of Psychiatrists and the American Psychiatric Association. She is the founding chair of the Neuroimaging Section of the EPA and the Neuroimaging Network of the European College of Neuropsychopharmacology. She co-chairs the Lifespan Working Group of the Enhancing NeuroImaging Genetics Through Meta-Analysis (ENIGMA) consortium and the consortium for the investigation of Psychopathology and Allostatic Load Across the Lifespan (PALS). She is editor for European Psychiatry and Human Brain Mapping and member of the editorial board of major scientific journals.
Prof. Ahmadzadehfar received his medical degree from Guilan Medical University in Iran 1999 and did his residency in Nuclear Medicine in Germany at the Department of Nuclear Medicine, University Hospital Bonn 2003-2008. From 2008 to 2013 he was the assistant medical director of the Department of Nuclear Medicine University Hospital Bonn and from 2013 works as the head of the therapy section. 2013-2015 he studied medical technique at the university hospital Bonn and received his MSc. Prof. Ahmadzadehfar serves as an editor and reviewer for several international journals and has authored and coauthored over 120 papers and book chapters. His main research area is targeted radionuclide therapy and Theranostics (like radionuclide therapy of NEN using PRRT, radioemboliazion of liver tumors and radioligand therapy of metastatic prostate cancer using Lu-PSMA).
Imaging@Brisbane 2018 is hosted by seven major research centres involved across three significant multi-modal medical imaging facilities located in the state's capital. This unique multi-disciplinary collaboration forges the foundation for a conference that will attract world-wide attendance and showcase all that medical imaging innovation has to offer health care now, and into the future.©Imaging@Brisbane 2018